miR-325-3p Reduces Proliferation and Promotes Apoptosis of Gastric Cancer Cells by Inhibiting Human Antigen R

被引:2
|
作者
Huang, Zhengwei [1 ,2 ]
Luo, Yacan [1 ]
Chen, Congcong [2 ]
Zhou, Chaoyang [3 ]
Su, Zhengkang [2 ]
Cai, Chang [1 ]
Li, Xi [2 ]
Wu, Wenzhi [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Zhejiang Prov Clin Res Ctr Mental Disorder, Affiliated Kangning Hosp, Wenzhou, Peoples R China
[3] Peoples Hosp Yuhuan, Intens Care Unit, Yuhuan, Peoples R China
关键词
BINDING PROTEIN HUR; IDENTIFICATION; PROGRESSION; EXPRESSION; XENOGRAFT; TARGET;
D O I
10.1155/2023/6882851
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Human antigen R (HuR), also known as ELAVL1, is a widely expressed RNA-binding protein (RBP) that has a significant impact on the development and advancement of tumors. Our previous study found that 5-fuorouracil (5-FU) may impede the proliferation and increase apoptosis in gastric cancer cells by reducing the nucleocytoplasmic shuttling of HuR. However, how posttranscriptional regulation infuences HuR functions in gastric cancer remains to be elucidated. Here, we demonstrated that miR-325-3p has the potential to regulate the expression level of HuR by directly binding to its 3 ' UTR, which in turn led to a significant reduction in proliferation and an increase in apoptosis in gastric cancer cells. In addition, xenograft experiment showed that knockdown of HuR or overexpression of miR-325-3p group exhibited smaller tumor sizes after transplant of gastric cancer cells into zebrafish larvae. Thus, our findings offer new insights into the pathogenesis of gastric cancer and may potentially assist in identifying novel targets for drug therapy.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] miR-325-3p Promotes the Proliferation, Invasion, and EMT of Breast Cancer Cells by Directly Targeting S100A2
    Wang, Huiling
    Hu, Xin
    Yang, Feng
    Xiao, Hui
    ONCOLOGY RESEARCH, 2020, 28 (7-8) : 731 - 744
  • [2] miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3
    Sun, Shaopeng
    Liu, Feng
    Xian, Shaozhong
    Cai, Dawei
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [3] MiR-325-3p promotes locomotor function recovery in rats with spinal cord injury via inhibiting the expression of neutrophil elastase
    Sun, J-D
    Zeng, Y-H
    Zhang, Y.
    Yang, X-X
    Zeng, W-J
    Zhao, L-S
    Liang, C-G
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (24) : 10631 - 10637
  • [4] CircHIPK3 promotes proliferation and metastasis and inhibits apoptosis of renal cancer cells by inhibiting MiR-485-3p
    Lai, Jinjin
    Xin, Jun
    Fu, Changde
    Zhang, Wei
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [5] CircHIPK3 promotes proliferation and metastasis and inhibits apoptosis of renal cancer cells by inhibiting MiR-485-3p
    Jinjin Lai
    Jun Xin
    Changde Fu
    Wei Zhang
    Cancer Cell International, 20
  • [6] SNHG6 Interacted with miR-325-3p to Regulate Cisplatin Resistance of Gastric Cancer by Targeting GITR
    Sun, Tuanhe
    Li, Kang
    Zhu, Kun
    Yan, Rong
    Dang, Chengxue
    Yuan, Dawei
    ONCOTARGETS AND THERAPY, 2020, 13 : 12181 - 12193
  • [7] miR-377-3p suppresses cell proliferation and promotes apoptosis of prostate cancer cells
    Jia, Yunpeng
    Dong, Hai
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06): : 6892 - 6900
  • [8] miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3
    Song, Yu
    Guo, Qisang
    Gao, Shujun
    Hua, Keqin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 516 (03) : 872 - 879
  • [9] miR-590-3p inhibits proliferation and promotes apoptosis by targeting activating transcription factor 3 in human breast cancer cells
    Rohini, M.
    Gokulnath, M.
    Miranda, P. J.
    Selvamurugan, N.
    BIOCHIMIE, 2018, 154 : 10 - 18
  • [10] Punicalagin Restricts Growth, Promotes Apoptosis, and Reduces Invasion in Human Gastric Cancer Cells
    Sun, Ding-Ping
    Uen, Yih-Huei
    Kang, Nai-Wen
    Chang, Chun-Chao
    Tian, Yu-Feng
    Fang, Chia-Lang
    Lin, Kai-Yuan
    DOSE-RESPONSE, 2024, 22 (02):